Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage pharmaceutical development company, is pleased to announce that it has ...
Polyrizon reports publication of US national patent application for innovative hydrogel nasal technologies: Raanana, Israel Thursday, January 2, 2025, 16:00 Hrs [IST] Polyrizon Lt ...